We serve Chemical Name:3-iodo-N-methoxy-N-methylbenzamide CAS:170282-53-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-iodo-N-methoxy-N-methylbenzamide
CAS.NO:170282-53-8
Synonyms:N-methoxy-N-methyl-3-iodobenzamide;Benzamide,3-iodo-N-methoxy-N-methyl;3-iodo-N-methoxy-N-methyl-benzamide
Molecular Formula:C9H10INO2
Molecular Weight:291.08600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.54000
Exact Mass:290.97600
LogP:1.92460
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-methoxy-N-methyl-3-iodobenzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-iodo-N-methoxy-N-methyl-benzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-iodo-N-methoxy-N-methyl-benzamide Use and application,3-iodo-N-methoxy-N-methyl-benzamide technical grade,usp/ep/jp grade.
Related News: The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. butan-2-yl-dimethoxy-(2-methylpropyl)silane manufacturers The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. 4-Quinolinol, 7-ethyl-3-(1-methyl-1H-tetrazol-5-yl)- suppliers The publication of the R&D People and Culture Strategy comes alongside the launch of the Innovation Strategy, which aims to make the UK a global hub for innovation and increase business investment in R&D. 10-Nitro-1-Oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid ethyl ester vendor & factory Another critically important benefit of biocatalytic processes is that they are far more eco-efficient than conventional methods. This is because enzymes, being originally derived from natural products, generally perform best under mild (often ambient) conditions. ,The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005.
